Tectonic Therapeutic (TECX) Debt Ratio (2021 - 2023)

Tectonic Therapeutic's (TECX) quarterly Debt Ratio came in at 0.19 in Q1 2023, up 115.97% year-on-year from 0.09 in Q1 2022, and up 25.89% on a QoQ basis from 0.15 in Q4 2022.

Tectonic Therapeutic (TECX) Debt Ratio (2021 - 2023) Analysis & Trends

Tectonic Therapeutic (TECX) has 3 years of Debt Ratio data on file, last reported at 0.19 in Q1 2023.

  • On a quarterly basis, Debt Ratio rose 115.97% year-over-year to 0.19 in Q1 2023; TTM through Mar 2023 was 0.19, a 115.97% increase from a year earlier, with the FY2022 full-year figure at 0.15, up 100.44% from the prior year.
  • Debt Ratio for Q1 2023 stood at 0.19, up from 0.15 in the prior quarter.
  • Over the last five years, Debt Ratio for TECX reached as high as 0.19 in Q1 2023 and fell as low as 0.07 in Q4 2021.
  • Historically, Debt Ratio has averaged 0.12 across 3 years, with a median of 0.11 in 2022.
  • Across the five-year window, Debt Ratio surged 100.44% in 2022 and soared 115.97% in 2023, its largest moves.
  • Year by year, Debt Ratio stood at 0.07 in 2021, then jumped by 100.44% to 0.15 in 2022, then advanced by 25.89% to 0.19 in 2023.
  • Per Business Quant data, the three most recent Debt Ratio figures were 0.19 in Q1 2023, 0.15 in Q4 2022, and 0.12 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Tectonic Therapeutic 595.23 Mn 595.23 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 0.19
Dec 31, 2022 0.15
Sep 30, 2022 0.12
Jun 30, 2022 0.10
Mar 31, 2022 0.09
Dec 31, 2021 0.07